Factors associated with D-dimer levels in HIV-infected individuals

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Borges, Álvaro H ^a   O'Connor, Jemma L ^b   Phillips, Andrew N ^b   Baker, Jason V ^c,d   Vjecha, Michael J ^e   Losso, Marcelo H ^f   Klinker, Hartwig ^g   Lopardo, Gustavo ^h   Williams, Ian ^b   Lundgren, Jens D ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f HOSPITAL RAMOS MEJÍA   (Argentina)

^g UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^h Fundacion Centro de Estudios Infectologicos   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYSTATIN C; D DIMER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYALURONIC ACID; INTERLEUKIN 6; VIRUS RNA; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CD4 LYMPHOCYTE COUNT; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; GROUPS BY AGE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED INFECTION; RACISM; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOKING; VIREMIA; VIRUS LOAD; BLOOD; HEPATITIS; INFLAMMATION; METABOLISM; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL MODEL; VIROLOGY;

ADULT; BIOMARKERS; C-REACTIVE PROTEIN; CD4 LYMPHOCYTE COUNT; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEPATITIS; HIV INFECTIONS; HUMANS; INFLAMMATION; INTERLEUKIN-6; LINEAR MODELS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX FACTORS; VIRAL LOAD;

EID: 84898739886     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090978     Document Type: Article

References (36)

1. Calmy A, Gayet-Ageron A, Montecucco F, Nguyen A, Mach F, et al. (2009) HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial. AIDS 23: 929-939.
2. Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, et al. (2010) Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 201: 1788-1795.
3. El-Sadr WM, Lundgren J, Neaton JD, Gordin F, Abrams D, et al. (2006) CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 355: 2283-2296. (Pubitemid 44837777)
4. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, et al. (2008) Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 5: e203.
5. Ledwaba L, Tavel JA, Khabo P, Maja P, Qin J, et al. (2012) Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease. PLoS One 7: e24243.
6. Baker JV, Neuhaus J, Duprez D, Kuller LH, Tracy R, et al. (2011) Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection. J Acquir Immune Defic Syndr 56: 36-43.
7. Funderburg NT, Mayne E, Sieg SF, Asaad R, Jiang W, et al. (2010) Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood 115: 161-167.
8. Baker J, Quick H, Hullsiek KH, Tracy R, Duprez D, et al. (2010) IL-6 and D-dimer levels are associated with vascular dysfunction in patients with untreated HIV infection. HIV Med 11: 608-609.
9. Harper PL, Theakston E, Ahmed J, Ockelford P (2007) D-dimer concentration increases with age reducing the clinical value of the D-dimer assay in the elderly. Intern Med J 37: 607-613. (Pubitemid 47262895)
10. Armah KA, McGinnis K, Baker J, Gibert C, Butt AA, et al. (2012) Burden of Comorbid Disease and Biomarkers of Inflammation, Altered Coagulation and Monocyte Activation. Clin Infect Dis 55: 126-136.
11. Hager K, Platt D. (1995) Fibrin degeneration product concentrations (D-dimers) in the course of ageing. Gerontology 41: 159-165.
12. Pieper CF, Rao KM, Currie MS, Harris TB, Cohen HJ (2000) Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons. J Gerontol A Biol Sci Med Sci 55: M649-657. (Pubitemid 32010310)
13. Fichtenbaum CJ (2011) Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection. Curr Infect Dis Rep 13: 94-101.
14. Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, et al. (2009) Interleukin-2 therapy in patients with HIV infection. N Engl J Med 2009; 361: 1548-1559.
15. Cockcroft DW, Gault MH. (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41.
16. Tedaldi E, Peters L, Neuhaus J, Puoti M, Rockstroh J, et al. (2008) Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study. Clin Infect Dis 47: 1468-1475.
17. Peters L, Neuhaus J, Mocroft A, Soriano V, Rockstroh J, et al. (2011) Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study. Antivir Ther 16: 667-675.
18. Di Castelnuovo A, de Curtis A, Costanzo S, Persichillo M, Olivieri M, et al. (2013) Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study. Haematologica 98: 1476-1480.
19. Folsom AR, Delaney JA, Lutsey PL, Zakai NA, Jenny NS, et al. (2009) Associations of factor VIIIc, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality. Am J Hematol 84: 349-353.
20. Khaleghi M, Saleem U, McBane RD, Mosley TH Jr, Kullo IJ (2009) African-American ethnicity is associated with higher plasma levels of D-dimer in adults with hypertension. J Thromb Haemost 7: 34-40.
21. Lange LA, Reiner AP, Carty CL, Jenny NS, Cushman M, et al. (2008) Common genetic variants associated with plasma fibrin D-dimer concentration in older European- and African-American adults. J Thromb Haemost 6: 654-659. (Pubitemid 351404933)
22. Kabrhel C, Mark Courtney D, Camargo CA Jr, et al. (2010) Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism. Acad Emerg Med 17: 589-597.
23. Lassila R, Peltonen S, Lepäntalo M, Saarinen O, Kauhanen P, et al. (1993) Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. Arterioscler Thromb Vasc Biol 13: 1738-1742. (Pubitemid 23360559)
24. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP (2002) Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 22: 201-210. (Pubitemid 34127028)
25. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, et al. (2005) Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 143: 697-706.
26. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, et al. (2009) Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 15: 955-959.
27. Shorr AF, Thomas SJ, Alkins SA, Fitzpatrick TM, Ling GS (2002) D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest 121: 1262-1268. (Pubitemid 34280452)
28. Stouthard JM, Levi M, Hack CE, Veenhof CH, Romijn HA, et al. (1996) Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 76: 738-742. (Pubitemid 26388179)
29. Robson SC, Shephard EG, Kirsch RE (1994) Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 86: 322-326. (Pubitemid 24198995)
30. Baker J, Ayenew W, Quick H, Hullsiek KH, Tracy R, et al. (2010) High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection. J Infect Dis 201: 285-292.
31. Mineo C, Deguchi H, Griffin JH, Shaul PW (2006) Endothelial and antithrombotic actions of HDL. Circ Res 98: 1352-1364. (Pubitemid 43948059)
32. Spadaro A, Tortorella V, Morace C, Fortiguerra A, Composto P, et al. (2008) High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis. World J Gastroenterol 14: 1549-1552. (Pubitemid 351460170)
33. Baker JV, Brummel-Ziedins K, Neuhaus J, Duprez D, Cummins N, et al. (2013) HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation. J Am Heart Assoc 2: e000264.
34. Gordge MP, Faint RW, Rylance PB, Ireland H, Lane DA, et al. (1989) Plasma D dimer: a useful marker of fibrin breakdown in renal failure. Thromb Haemost 61: 522-525. (Pubitemid 19168168)
35. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, et al. (2003) Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107: 87-92. (Pubitemid 36070938)
36. Lee AJ, Fowkes GR, Lowe GD, Rumley A (1995) Determinants of fibrin D-dimer in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 15: 1094-1097.